#Japan #pharmaceutical #Interphex #Chiba #RosettaAI

Rosetta Unveils Advanced AI Solutions for the Pharmaceutical Industry at INTERPHEX Week Tokyo 2026

Rosetta, a subsidiary of Metareal, will exhibit its state-of-the-art AI solutions tailored for the pharmaceutical sector at "INTERPHEX Week Tokyo/Pharma DX EXPO Tokyo" from May 20-22, 2026, at Makuhari Messe. This event is organized by RX Japan, and Rosetta will showcase its booth at Hall 4, number 18-18. The company’s cutting-edge AI translation service, known as "Rakuyaku AI," is the number one AI translation service in the domestic market, focusing specifically on the unique needs of the pharmaceutical industry.

Enhancing Efficiency in Pharmaceutical Documentation

Rosetta's innovative solutions leverage generative AI technology to streamline documentation processes within the pharmaceutical industry. By addressing inefficiencies in document creation, these tools play a significant role in accelerating the market availability of new drugs. At their booth, attendees will find a range of AI-driven products, including the new "Rakuyaku SOP Editor," "Rakuyaku Q&A Assist," and "Rakuyaku MW Editor," which are specifically designed to support the document preparation needs of pharmaceutical companies.

In addition, on May 21 from 11:40 AM to 12:10 PM, Rosetta will host a seminar focused on their AI tool, "Rakuyaku SOP Editor," which aims to accelerate the integration and standardization of SOPs in compliance with Good Manufacturing Practices (GMP). This seminar will be valuable for professionals involved in quality control, manufacturing, and digital transformation management in the pharmaceutical sector.

Comprehensive Overview of Exhibit Features

The exhibit will feature:

• - Rakuyaku AI: A SaaS product designed to enhance the efficiency of document creation, quality control, and information retrieval, facilitating customized AI tool development based on specific corporate needs. Rosetta enables flexible implementation from immediate SaaS adoption to fully customized development, tailored to align with each company’s operational flow.

• - Rakuyaku SOP Editor: An AI-based document integration tool that accelerates the standardization of SOPs to ensure compliance with GxP regulations.
• - Rakuyaku Q&A Assist: An AI solution that aids in managing Q&A tasks based on pharmaceutical documents, enhancing response efficiency.
• - Rakuyaku MW Editor: An AI-powered editor designed to assist in the creation and editing of medical writing documents, ensuring accuracy and compliance.

Seminar Details

Seminar Title: Accelerating SOP Integration and Standardization for GMP Compliance with AI "Rakuyaku SOP Editor"
Date & Time: May 21, 2026, from 11:40 AM to 12:10 PM
Location: Seminar Area #6 / Manufacturing and Quality Control DX Forum (Hall 4)
Participation: Free with prior registration required
Seminar Link: Learn More Here

About Rakuyaku AI and Rosetta

Rakuyaku AI, developed by Rosetta, is a cutting-edge generative AI SaaS solution designed specifically for the pharmaceutical industry. It automates the creation of specialized documents such as Clinical Study Reports (CSR) and package inserts, conducting integrity checks and translations to boost operational efficiency and reduce costs. By significantly speeding up the documentation process, Rakuyaku AI aids in enhancing the market launch speed of both innovative and generic pharmaceuticals.

For more on Rosetta and its offerings, visit their product site at Rosetta AI Product Site.

About Metareal Group

Metareal’s mission is to liberate people from constraints of time, place, and language. It ranks as the leader in the domestic translation market, building a robust customer base across various fields, including legal, pharmaceutical, finance, and IT. The company's commitment to custom AI development services aims to solve client-specific challenges and foster innovation.

To learn more about Metareal, visit Metareal Website.

Conclusion

With Rosetta's presentation of Rakuyaku AI and its specialized solutions at INTERPHEX Week Tokyo 2026, professionals in the pharmaceutical realm can expect to discover unparalleled opportunities to enhance their document management processes, ensuring compliance and accelerating their operational efficiency.